Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -430.43% is 52% below its 5-year average of -283.01%, around the middle of its 5-year range (-1118.99%–-126.41%).
0.81% above its 12-month average of -433.95%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-07-31): -201.26%.
NET PROFIT MARGIN
-430.43%
NET PROFIT MARGIN AVG TTM
-433.95%
NET PROFIT MARGIN AVG 3Y
-292.35%
NET PROFIT MARGIN AVG 5Y
-283.01%
NET PROFIT MARGIN AVG 10Y
-276.87%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.81%
CURRENT VS 3Y AVG
-47.23%
CURRENT VS 5Y AVG
-52.09%
CURRENT VS 10Y AVG
-55.46%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-165450.00%
vs the sector median at left
Nutriband Inc.
Market Cap
$83.21M
Net Profit Margin
-430.43%
TTM Avg
-433.95%
3Y Avg
-292.35%
5Y Avg
-283.01%
Market Cap
$83.24M
Net Profit Margin
-7884.06%
TTM Avg
-7191.86%
3Y Avg
-8225.67%
5Y Avg
-7676.39%
Market Cap
$83.61M
Net Profit Margin
-269.42%
TTM Avg
-19.58%
3Y Avg
-904.79%
5Y Avg
-881.91%
Market Cap
$82.78M
Net Profit Margin
57.57%
TTM Avg
-58.69%
3Y Avg
-51.95%
5Y Avg
-56.60%
Market Cap
$84.14M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.20M
Net Profit Margin
-1168.20%
TTM Avg
-1464.39%
3Y Avg
-946.48%
5Y Avg
-672.82%
Market Cap
$82.19M
Net Profit Margin
-4560.82%
TTM Avg
-1001.79%
3Y Avg
-692.03%
5Y Avg
-1554.36%
Market Cap
$81.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-72272.26%
Market Cap
$81.85M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $83.21M | -430.43% | -433.95% | -292.35% | -283.01% |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.24M | -7884.06% | -7191.86% | -8225.67% | -7676.39% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.61M | -269.42% | -19.58% | -904.79% | -881.91% |
| LENSAR Inc (LNSR)vs › | $82.78M | 57.57% | -58.69% | -51.95% | -56.60% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| MediciNova, Inc. (MNOV)vs › | $82.20M | -1168.20% | -1464.39% | -946.48% | -672.82% |
| Humacyte, Inc. (HUMA)vs › | $82.19M | -4560.82% | -1001.79% | -692.03% | -1554.36% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $81.88M | 0.00% | 0.00% | 0.00% | -72272.26% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $81.85M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-408.4%
Net Profit Margin
-430.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | -201.26% |
| 2026-04-30 | -286.56% |
| 2026-01-31 | -241.59% |
| 2025-10-31 | -1118.99% |
| 2025-07-31 | -321.36% |
| 2025-04-30 | -208.09% |
| 2025-01-31 | -858.68% |
| 2024-10-31 | -211.06% |
| 2024-07-31 | -385.02% |
| 2024-04-30 | -464.61% |
| 2024-01-31 | -358.54% |
| 2023-10-31 | -411.36% |
| 2023-07-31 | -126.41% |
| 2023-04-30 | -212.87% |
| 2023-01-31 | -318.33% |
| 2022-10-31 | -174.67% |
| 2022-07-31 | -228.68% |
| 2022-04-30 | -145.23% |
| 2022-01-31 | -766.11% |
| 2021-10-31 | -555.34% |
| 2021-07-31 | -243.25% |
| 2021-04-30 | -72.89% |
| 2021-01-31 | -647.01% |
| 2020-10-31 | -10.87% |
| 2020-07-31 | -267.46% |
| 2020-04-30 | -345.33% |
| 2020-01-31 | -4824.21% |
| 2019-10-31 | -912.32% |
| 2019-07-31 | -601.45% |
| 2019-04-30 | -296.17% |
| 2019-01-31 | -625.38% |
| 2018-10-31 | -300.11% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | 0.00% |
| 2017-04-30 | 0.00% |
| 2017-01-31 | 0.00% |
| 2016-10-31 | 0.00% |
| 2016-07-31 | 0.00% |
| 2016-04-30 | 0.00% |
| 2016-01-31 | 0.00% |
